PerspectivePublished 22 Nov 2022
Goals for the treatment of obesity using new pharmaceuticals and non-pharmacological agents
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type 2 diabetes, the primary metabolic complication of obesity, has become a global epidemic, necessitating the development of fresh approaches to both treating and preventing the disease. While essential for treating obesity, a good diet and regular exercise are frequently insufficient. Pharmacotherapy can help with compliance maintenance, reducing obesity-related health concerns, and enhancing quality of life. In the last two decades, there has been a tremendous improvement in our understanding of the cerebral and peripheral mechanisms driving homeostatic and hedonic aspects of food intake. Obesity may result from an imbalance in one or more of these factors.details summary { cursor: pointer; color: #ffff; } a { font-size: 11px; opacity: 0.5; }ReferencesCar Insurance in Oklahoma Blog | Real Estate in Greece
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacology and Medicinal Chemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Silverio Perrotta”
- BylineArticles whose byline prints “Maya Buch”
